JCVI advises extending COVID-19 booster programme
All adults aged 40- to 49-years-old to be offered an mRNA vaccine booster dose
Read More
Author: Lucy Parsons
Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis
Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Read More
NICE ‘no’ for BioMarin’s Vimizin
The draft guidance has been published following an evaluation of new evidence on the use of the treatment
Read More
New drug combination highly effective in children with leukaemia
APL is an acute leukaemia, meaning it develops quickly and requires immediate treatment
Read More
New COVID-19 vaccines could target replication proteins
Researchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
